<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-125091</identifier>
<setSpec>1137-6821</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Experience using prothrombin complex concentrate in a hospital emergency department</dc:title>
<dc:description xml:lang="en">Objective: To describe short-term results of emergency department (ED) use of a prothrombin complex concentrate(PCC) in the context of routine hospital practice. Methods: Retrospective observational nonintervention study including all patients who were injected with a PCC in the ED during 19 months. Demographic, clinical, laboratory, and treatment data were gathered from patient records. The main outcome variables were an international normalized ratio (INR) of 1.5 or less and resolution of bleeding after injection of the PCC. Secondary outcomes were hospital admission, in-hospital and 6-month mortality, and occurrence of pulmonary embolism within 6 months of PCC injection. The patient sample was analyzed according to the indication for PCC use. Results: Seventy-five patients with a mean (SD) age of 77.2 (12.18) years were included; 45 (60%) were men. Sixty-sixpatients (88%) had received an anticoagulant. The indications for PCC use were severe hemorrhage in 48 (64.0%),minor bleeding in 8 (10.6%), surgery or another invasive procedure in 15 (20.0%), and INR elevation without evident bleeding in 2 (2.7%). The mean PCC dosage was 1271 (416) IU. An INR of 1.5 or less was achieved in 54 of the 75patients (72.0%); bleeding stopped in 53 (94.7%) of those with severe hemorrhage. Sixty-one patients (81.3%) were admitted, and 16 (21.3%) died in hospital. At 6 months, 1 patient (1.3%) had died after discharge and 2 (2.7%) had experienced pulmonary thromboembolism. Conclusion: Use of a PCC in addition to usual management is effective and relatively safe for routine ED practice (AU)</dc:description>
<dc:creator>Borobia, A. M</dc:creator>
<dc:creator>Zegarra, C</dc:creator>
<dc:creator>García-Erce, J. A</dc:creator>
<dc:creator>Martínez Virto, A. M</dc:creator>
<dc:creator>Rivera Núñez, M. A</dc:creator>
<dc:creator>Quintana Díaz, M</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se describen los resultados a corto plazo del uso de los concentrados de complejo protrombínico(CCP) según la práctica clínica habitual en los pacientes atendidos en un servicio de urgencias hospitalario (SUH). Estudio observacional longitudinal retrospectivo que incluyó a todos los pacientes que habían recibido CCP en un SUH durante 19 meses. Se recogieron variables demográficas, clínicas, analíticas y de manejo a partir de la historia clínica. Las variables principales de resultado fueron presentar un (..)  (AU)</dc:description>
<dc:source>Emergencias (Sant Vicenç dels Horts);26(4): 303-306, ago. 2014. tab</dc:source>
<dc:identifier>ibc-125091</dc:identifier>
<dc:title xml:lang="es">Experiencia del uso de los concentrados de complejo protrombínico en un servicio de urgencias hospitalario</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d6622^s22067</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d28625</dc:subject>
<dc:subject>^d4707^s22083</dc:subject>
<dc:subject>^d51716^s22083</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d4713^s22083</dc:subject>
<dc:subject>^d22270^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201408</dc:date>
</metadata>
</record>
</ibecs-document>
